4,692
Views
9
CrossRef citations to date
0
Altmetric
Review

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

, , & ORCID Icon
Article: 1794424 | Received 28 Jun 2020, Accepted 06 Jul 2020, Published online: 16 Jul 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.